HealthcareServices

Herceptin Market Insights Report: Opportunities and Drivers 2030

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the herceptin market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Herceptin Market between 2026 and 2030?

The herceptin market has experienced substantial growth in recent years. It is projected to expand from $7.48 billion in 2025 to $7.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. Historically, this expansion was fueled by several factors, including the increased diagnosis of her2-positive cancer, widespread clinical adoption of trastuzumab, advancements in oncology infusion infrastructure, the availability of biologic manufacturing capabilities, and the integration of herceptin into standard treatment guidelines.

The herceptin market is projected to experience substantial expansion over the coming years, reaching a valuation of $9.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8%. This anticipated growth can be linked to several factors, including heightened biosimilar competition, a growing need for cost-effective biologic treatments, the expansion of targeted oncology development pipelines, greater uptake of individualized cancer therapies, and increased funding in biologic drug innovation. Key developments anticipated during this period involve the rising acceptance of biosimilar trastuzumab offerings, increased utilization of subcutaneous drug delivery methods, the broadening of combination therapy approaches, a stronger emphasis on economical biologic solutions, and improved oversight of treatment results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24236&type=smp

Which Drivers Are Expected To Impact The Herceptin Market During The Forecast Period?

The rising occurrence of breast cancer is projected to significantly drive the expansion of the herceptin market in the foreseeable future. This malignancy originates in the breast’s cells, typically developing within the milk ducts or lobules. Its forms encompass invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and HER2-positive breast cancer. A contributing factor to the increase in breast cancer cases includes shifts in lifestyle habits, like greater alcohol intake, unhealthy diets, and insufficient physical exercise, all of which elevate risk. With a growing number of breast cancer diagnoses, especially those identified as HER2-positive, the need for potent targeted treatments like herceptin steadily escalates. For example, the American Cancer Society, a US-based cancer organization, predicted in January 2025 that an estimated 319,750 new breast cancer cases would be reported in 2025, alongside projections of approximately 42,680 fatalities attributed to the illness. Consequently, the escalating incidence of breast cancer is a key factor propelling the expansion of the herceptin market.

Which Segments Are Driving Activity In The Herceptin Market?

The herceptin market covered in this report is segmented –

1) By Product: Biologic, Biosimilar

2) By Application: Breast Cancer, Gastric Cancer

3) By Payer: Commercial And Private, Public

4) By Distribution Channel: Hospital Pharmacy, Specialty Pharmacy

Subsegments:

1) By Biologic: Intravenous (IV) Biologics, Subcutaneous (SC) Biologic

2) By Biosimilar: Intravenous (IV) Biosimilars, Subcutaneous (SC) Biosimilars

What Trends Are Reshaping The Dynamics Of The Herceptin Market?

Leading companies engaged in the herceptin market are actively developing innovative treatment approaches, such as advanced biosimilar products, to broaden patient access and enhance therapeutic outcomes for individuals with HER2-positive cancers. These innovative biosimilar products are highly similar versions of already approved biologic medications, manufactured using sophisticated biotechnology to ensure equivalent safety, efficacy, and quality. For example, in April 2024, Accord BioPharma Inc., a US-based pharmaceutical company, received approval from the U.S. Food and Drug Administration for HERCESSI (trastuzumab-strf), a biosimilar to herceptin (trastuzumab), designated for treating HER2-overexpressing breast and gastric cancers. Biosimilars like HERCESSI demonstrate effectiveness and safety comparable to their reference biologics, while also potentially providing more cost-efficient treatment alternatives.

Which Major Firms Are Strengthening Their Position In The Herceptin Market?

Major companies operating in the herceptin market are Roche Holding AG, Pfizer Inc., Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Biocon Limited, Dr. Reddy’s Laboratories, Celltrion Inc., Samsung Biologics, Fresenius Kabi, Intas Pharmaceuticals Ltd, Zydus Lifesciences Ltd, AryoGen Pharmed, Shanghai Henlius Biotech Inc., Prestige Biopharma Pte Ltd, Alvotech, Coherus BioSciences, BioXpress Therapeutics, Amneal Pharmaceuticals, Novartis AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/herceptin-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Herceptin Market?

North America was the largest region in the herceptin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herceptin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Herceptin Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24236&type=smp

Browse Through More Reports Similar to the Global Herceptin Market 2026, By The Business Research Company

Genital Herpes Market Report 2026

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Oleoresin Market Report 2026

https://www.thebusinessresearchcompany.com/report/oleoresin-global-market-report

Epinephrine Market Report 2026

https://www.thebusinessresearchcompany.com/report/epinephrine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795